Didronel IV en es it fr

Didronel IV Brand names, Didronel IV Analogs

Didronel IV Brand Names Mixture

  • No information avaliable

Didronel IV Chemical_Formula


Didronel IV RX_link


Didronel IV fda sheet

Didronel IV msds (material safety sheet)

Didronel IV Synthesis Reference

No information avaliable

Didronel IV Molecular Weight

391.46 g/mol

Didronel IV Melting Point

No information avaliable

Didronel IV H2O Solubility

10 mg/L

Didronel IV State


Didronel IV LogP


Didronel IV Dosage Forms

Tablets (100 mg)

Didronel IV Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

Didronel IV Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Didronel IV Absorption

Well absorbed from gastrointestinal tract.

Didronel IV side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

Didronel IV Patient Information

Didronel IV Organisms Affected

Humans and other mammals